479 related articles for article (PubMed ID: 29337773)
21. Redefining the Ki-67 Index Stratification for Low-Grade Pancreatic Neuroendocrine Tumors: Improving Its Prognostic Value for Recurrence of Disease.
Lopez-Aguiar AG; Ethun CG; Postlewait LM; Zhelnin K; Krasinskas A; El-Rayes BF; Russell MC; Sarmiento JM; Kooby DA; Staley CA; Maithel SK; Cardona K
Ann Surg Oncol; 2018 Jan; 25(1):290-298. PubMed ID: 29079920
[TBL] [Abstract][Full Text] [Related]
22. Predictive Factors for Lymph Node Metastasis and Prognostic Factors for Survival in Rectal Neuroendocrine Tumors.
Sohn B; Kwon Y; Ryoo SB; Song I; Kwon YH; Lee DW; Moon SH; Park JW; Jeong SY; Park KJ
J Gastrointest Surg; 2017 Dec; 21(12):2066-2074. PubMed ID: 29047070
[TBL] [Abstract][Full Text] [Related]
23. The effect of circumferential tumor location in clinical outcomes of rectal cancer patients treated with total mesorectal excision.
Lee SH; Hernandez de Anda E; Finne CO; Madoff RD; Garcia-Aguilar J
Dis Colon Rectum; 2005 Dec; 48(12):2249-57. PubMed ID: 16400512
[TBL] [Abstract][Full Text] [Related]
24. Pathologic Complete Response in Rectal Cancer: Can We Detect It? Lessons Learned From a Proposed Randomized Trial of Watch-and-Wait Treatment of Rectal Cancer.
Nahas SC; Rizkallah Nahas CS; Sparapan Marques CF; Ribeiro U; Cotti GC; Imperiale AR; Capareli FC; Chih Chen AT; Hoff PM; Cecconello I
Dis Colon Rectum; 2016 Apr; 59(4):255-63. PubMed ID: 26953983
[TBL] [Abstract][Full Text] [Related]
25. Prognostic factors for disease relapse in patients with neuroendocrine tumours who underwent curative surgery.
Slagter AE; Ryder D; Chakrabarty B; Lamarca A; Hubner RA; Mansoor W; O'Reilly DA; Fulford PE; Klümpen HJ; Valle JW; McNamara MG
Surg Oncol; 2016 Sep; 25(3):223-8. PubMed ID: 27566026
[TBL] [Abstract][Full Text] [Related]
26. Risk Factors Associated With Circumferential Resection Margin Positivity in Rectal Cancer: A Binational Registry Study.
Warrier SK; Kong JC; Guerra GR; Chittleborough TJ; Naik A; Ramsay RG; Lynch AC; Heriot AG
Dis Colon Rectum; 2018 Apr; 61(4):433-440. PubMed ID: 29521824
[TBL] [Abstract][Full Text] [Related]
27. Clinical outcomes of endoscopic mucosal resection for rectal neuroendocrine tumor.
Kim J; Kim JH; Lee JY; Chun J; Im JP; Kim JS
BMC Gastroenterol; 2018 Jun; 18(1):77. PubMed ID: 29866049
[TBL] [Abstract][Full Text] [Related]
28. The Importance of a Minimal Tumor-Free Resection Margin in Locally Recurrent Rectal Cancer.
Alberda WJ; Verhoef C; Schipper ME; Nuyttens JJ; Rothbarth J; de Wilt JH; Burger JW
Dis Colon Rectum; 2015 Jul; 58(7):677-85. PubMed ID: 26200682
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the concordance between the stage of the disease and Ki-67 proliferation index in gastroenteropancreatic neuroendocrine tumors.
Özaslan E; Demir S; Karaca H; Güven K
Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):836-41. PubMed ID: 26945127
[TBL] [Abstract][Full Text] [Related]
30. Transanal endoscopic microsurgery for residual rectal cancer (ypT0-2) following neoadjuvant chemoradiation therapy: another word of caution.
Perez RO; Habr-Gama A; Lynn PB; São Julião GP; Bianchi R; Proscurshim I; Gama-Rodrigues J
Dis Colon Rectum; 2013 Jan; 56(1):6-13. PubMed ID: 23222274
[TBL] [Abstract][Full Text] [Related]
31. Surgical salvage of recurrent rectal cancer after transanal excision.
Weiser MR; Landmann RG; Wong WD; Shia J; Guillem JG; Temple LK; Minsky BD; Cohen AM; Paty PB
Dis Colon Rectum; 2005 Jun; 48(6):1169-75. PubMed ID: 15793645
[TBL] [Abstract][Full Text] [Related]
32. Predictors of Metastases in Rectal Neuroendocrine Tumors: Results of a National Cohort Study.
Concors SJ; Sinnamon AJ; Folkert IW; Mahmoud NN; Fraker DL; Paulson EC; Roses RE
Dis Colon Rectum; 2018 Dec; 61(12):1372-1379. PubMed ID: 30312223
[TBL] [Abstract][Full Text] [Related]
33. Gadolinium-Based Contrast Agent During Pelvic MRI: Contribution to Patient Management in Rectal Cancer.
Corines MJ; Nougaret S; Weiser MR; Khan M; Gollub MJ
Dis Colon Rectum; 2018 Feb; 61(2):193-201. PubMed ID: 29337774
[TBL] [Abstract][Full Text] [Related]
34. Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67.
Genç CG; Falconi M; Partelli S; Muffatti F; van Eeden S; Doglioni C; Klümpen HJ; van Eijck CHJ; Nieveen van Dijkum EJM
Ann Surg Oncol; 2018 Aug; 25(8):2467-2474. PubMed ID: 29789972
[TBL] [Abstract][Full Text] [Related]
35. A prospective multicenter clinical study of extralevator abdominoperineal resection for locally advanced low rectal cancer.
Han JG; Wang ZJ; Qian Q; Dai Y; Zhang ZQ; Yang JS; Li F; Li XB
Dis Colon Rectum; 2014 Dec; 57(12):1333-40. PubMed ID: 25379997
[TBL] [Abstract][Full Text] [Related]
36. Transanal Endoscopic Microsurgery for Early Rectal Cancer: A Single-Center Experience.
O'Neill CH; Platz J; Moore JS; Callas PW; Cataldo PA
Dis Colon Rectum; 2017 Feb; 60(2):152-160. PubMed ID: 28059911
[TBL] [Abstract][Full Text] [Related]
37. Preoperative parameters expanding the indication of sphincter preserving surgery in patients with advanced low rectal cancer.
Ueno H; Mochizuki H; Hashiguchi Y; Ishikawa K; Fujimoto H; Shinto E; Hase K
Ann Surg; 2004 Jan; 239(1):34-42. PubMed ID: 14685098
[TBL] [Abstract][Full Text] [Related]
38. Long-term prognostic value of mesorectal grading after neoadjuvant chemoradiotherapy for rectal cancer.
Madbouly KM; Hussein AM; Abdelzaher E
Am J Surg; 2014 Sep; 208(3):332-41. PubMed ID: 24581995
[TBL] [Abstract][Full Text] [Related]
39. Lymphovascular invasion in more than one-quarter of small rectal neuroendocrine tumors.
Kwon MJ; Kang HS; Soh JS; Lim H; Kim JH; Park CK; Park HR; Nam ES
World J Gastroenterol; 2016 Nov; 22(42):9400-9410. PubMed ID: 27895428
[TBL] [Abstract][Full Text] [Related]
40. [Analysis on risk factors of positive vertical resection margin after endoscopic treatment of rectal neuroendocrine tumors].
Wang RG; Jiang X; Ren YT; Wang J; Guo XJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jul; 22(7):643-647. PubMed ID: 31302962
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
